Your browser doesn't support javascript.
loading
Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Barquín, Miguel; Calvo, Virginia; García-García, Francisco; Nuñez, Beatriz; Sánchez-Herrero, Estela; Serna-Blasco, Roberto; Auglyte, Milda; Carcereny, Enric; Rodriguez-Abreu, Delvys; López Castro, Rafael; Guirado, María; Camps, Carlos; Bosch-Barrera, Joaquín; Massuti, Bartomeu; Ortega, Ana Laura; Del Barco, Edel; Gonzalez-Larriba, José Luis; Aguiar, David; García-Campelo, Rosario; Dómine, Manuel; Agraso, Sara; Sala, Mª Angeles; Oramas, Juana; Bernabé, Reyes; Blanco, Remei; Parejo, Consuelo; Cruz, Alberto; Menasalvas, Ernestina; Royuela, Ana; Romero, Atocha; Provencio, Mariano.
Afiliação
  • Barquín M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Calvo V; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • García-García F; Bioinformatics & Biostatistics Unit, Príncipe Felipe Research Center, Valencia, Spain.
  • Nuñez B; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Sánchez-Herrero E; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Serna-Blasco R; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Auglyte M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Carcereny E; Institut Català d'Oncologia Badalona-Hospital Germans Trias i Pujol, B-ARGO GROUP Badalona Applied Research Group in Oncology, Badalona, Spain.
  • Rodriguez-Abreu D; Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • López Castro R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Guirado M; Hospital General Universitario de Elche, Elche, Spain.
  • Camps C; Hospital General Universitario de Valencia, Valencia, Spain.
  • Bosch-Barrera J; Catalan Institute of Oncology, Girona, Spain.
  • Massuti B; Hospital Universitario General de Alicante, Alicante, Spain.
  • Ortega AL; Complejo Hospitalario de Jaen, Jaen, Spain.
  • Del Barco E; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Gonzalez-Larriba JL; Hospital Clínico San Carlos, Madrid, Spain.
  • Aguiar D; Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas, Spain.
  • García-Campelo R; Hospital Universitario de la Coruña, La Coruña, Spain.
  • Dómine M; Hospital Fundación Jiménez Díaz, Madrid, Spain.
  • Agraso S; Complejo Hospitalario Universitario de Vigo, Vigo, Spain.
  • Sala MA; Hospital de Basurto, Bilbao, Spain.
  • Oramas J; Hospital Universitario de Canarias, Tenerife, Spain.
  • Bernabé R; Hospital Universitario Virgen del Rocio, Seville, Spain.
  • Blanco R; Hospital de Terrassa, Barcelona, Spain.
  • Parejo C; TIC Unit, Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Cruz A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Menasalvas E; Center for Biomedical Technology, Universidad Politécnica de Madrid, Madrid 28000, Spain.
  • Royuela A; Biostatistics Unit, CIBERESP, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Romero A; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: atocha10@hotmail.com.
  • Provencio M; Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Electronic address: mariano.provencio@salud.madrid.org.
Cancer Epidemiol ; 67: 101737, 2020 08.
Article em En | MEDLINE | ID: mdl-32450544
ABSTRACT

BACKGROUND:

Biological differences between the sexes have a major impact on disease and treatment outcome. In this paper, we evaluate the prognostic value of sex in stage IV non-small-cell lung cancer (NSCLC) in the context of routine clinical data, and compare this information with other external datasets.

METHODS:

Clinical data from stage IV NSCLC patients from Hospital Puerta de Hierro (HPH) were retrieved from electronic health records using big data analytics (N = 397). In addition, data from the Spanish Lung Cancer Group (GECP) Tumor Registry (N = 1382) and from a published study available from the cBioPortal (MSK) (N = 601) were analyzed. Survival curves were estimated using the Kaplan-Meier method. A Cox proportional hazards regression model was used to assess the prognostic value of sex. A meta-analysis to compare the outcome for males and females in terms of overall survival (OS) and progression free survival (PFS) was performed.

RESULTS:

The median OS time was 12 months for males and 19 months for females (overall HR = 0.77; 95% CI 0.68-0.87; P < 0.001). Similarly, females with stage IV NSCLC harboring an EGFR-sensitizing mutation lived significantly longer than males (median OS males, 19 months; females, 32 months) with a lower risk of death compared with males (overall HR = 0.75; 95% CI 0.67-0.84). In addition, female patients benefited more from EGFR inhibitors in terms of PFS and OS (overall HR = 0.45; 95% CI 0.32-0.64, and HR = 0.62; 95% CI 0.48-0.80, respectively). Median PFS was 21 months in females and 12 months in males (P < 0.001).

CONCLUSIONS:

Using routine clinical data we confirmed the previous finding that among stage IV NSCLC patients, females had a significantly better prognosis than males. The effect size of the sex was notable, highlighting the fact that survival rates are usually estimated and patients are generally managed without considering the sexes separately, which may lead to suboptimal results.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Epidemiol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Mutação Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Epidemiol Ano de publicação: 2020 Tipo de documento: Article